HERG Screening Market 2025–2029: Strategic Opportunities and Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the herg screening market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The HERG Screening Market Now And By 2029?

The pediatric drugs market size has seen rapid growth in recent years. It is forecast to expand from $157 billion in 2024 to $179.43 billion in 2025, achieving a compound annual growth rate (CAGR) of 14.3%. This historical growth can be linked to the demand for related medications, a large pediatric population, increased awareness of pediatric diseases, the expansion of pediatric oncology, the emergence of digital health and telemedicine, and greater collaboration in pediatric drug development.

The pediatric drugs market is projected to experience significant expansion over the coming years. This market is anticipated to reach $308.57 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.5%. Key drivers for this growth include a growing pediatric population, an increase in pediatric mental health concerns, a greater incidence of chronic conditions among children, improved childhood vaccination rates, and an escalating need for pediatric mental health treatments. Noteworthy trends shaping this period encompass personalized pediatric medicine approaches, the incorporation of technology into pediatric drug administration, the rise of telemedicine and digital health solutions, advancements in pediatric clinical trials, and strengthened cooperation between pediatricians and pharmacists.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp

Which Long-Term Drivers Are Expected To Sustain The HERG Screening Market?

The expansion of the pediatric drugs market is anticipated due to an increasing incidence of preterm births. Preterm births are defined as infants delivered prior to 37 weeks of gestation, a period shorter than the usual 40-week term. This rise in preterm births stems from various factors, including advanced maternal age, certain lifestyle choices, pre-existing medical conditions, multiple gestations, and insufficient prenatal care. Pediatric medications play a crucial role in supporting the health and developmental progress of preterm infants by providing specific treatments for issues like respiratory problems, infections, and nutritional gaps. For example, data released in December 2022 by Tommy’s, a UK-based charity organization, indicated that in 2022, the proportion of premature live births in England and Wales stood at 7.9%, an increase from 7.5% in 2021. This figure corresponds to more than 53,000 infants born prematurely in 2022. Consequently, the increasing prevalence of preterm births is a significant catalyst for the growth of the pediatric drugs market.

How Is The HERG Screening Market Classified By Different Segments?

The pediatric drugs market covered in this report is segmented –

1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs

2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids

2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)

3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives

4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents

What Current And Upcoming Trends Are Shaping The HERG Screening Market?

Leading companies in the pediatric drugs market are prioritizing the development of innovative medications, such as fully human monoclonal antibodies, to enhance treatment results and minimize adverse effects for young patients. A fully human monoclonal antibody (mAb) is an antibody entirely derived from human genetic sequences, which reduces the risk of immune system reactions compared to chimeric or humanized monoclonal antibodies. These antibodies are manufactured using advanced biotechnology techniques, including transgenic mice with human antibody genes or phage display technology. For instance, in August 2022, Johnson and Johnson, a US-based pharmaceutical industry company, obtained FDA approval for STELARA (ustekinumab) for the treatment of pediatric patients aged six years and older with active psoriatic arthritis (PsA). This approval signifies a major step forward, as STELARA is the first and only biologic therapy designed to target interleukin-12 (IL-12) and interleukin-23 (IL-23), which are key cytokines involved in inflammatory responses linked to autoimmune diseases. Active PsA is a rare condition affecting approximately 5-8% of children with chronic inflammatory arthritis, causing symptoms such as joint swelling and skin lesions.

Who Are The Primary Market Leaders In The HERG Screening Market?

Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report

Which Regional Markets Are Emerging As Key Centers For The HERG Screening Market?

North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=21249&type=smp

Browse Through More Reports Similar to the Global HERG Screening Market 2025, By The Business Research Company

Pediatric Dental Crown Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-dental-crown-global-market-report

Pediatric Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Pediatric Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795